相关实验视频

Updated: May 16, 2025

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

对表皮生长因子受体 (EGFR) 突变和肺腺癌中临床病理特征的相关性分析

Haitao Wang¹, Changhua Ji¹, Chengjun Zhou¹

¹Department of Pathology, The Second Hospital of Shandong University, Jinan, Shandong, China.

Frontiers in oncology

|April 4, 2025

概括

肺腺癌中的表皮生长因子受体 (EGFR) 突变与吸烟史,瘤大小,亚型,肌体分化和细胞外粘液相关. 这些特征可能有助于预测EGFR突变状态.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
病理学病理学病理学

背景情况:

肺腺癌是全球癌症死亡的重要原因之一.
表皮生长因子受体 (EGFR) 突变是肺腺癌的一个子集的关键驱动因素.
识别EGFR突变和临床病理特征之间的相关性可以帮助个性化治疗策略.

研究的目的:

研究肺腺癌患者EGFR突变与各种临床病理学特征之间的关联.
为了确定特定的组织学特征是否可以作为EGFR突变状态的预测因素.

主要方法:

对139例肺腺癌病例的回顾性分析.
使用放大耐火突变系统 (ARMS) 检测EGFR突变的分子检测.
收集和统计分析临床病理学数据,包括吸烟史,瘤大小,亚型,肌体分化和细胞外粘液.

主要成果:

在139例肺腺癌病例中,有96例发现了EGFR突变.
在EGFR突变和吸烟史 (P=0.0311),瘤大小 (P=0.0247),瘤亚型 (P=0.0003),肌体分化 (P=0.0237) 和细胞外粘液 (P=0.0013) 之间发现了显著的相关性.

结论:

特定的临床病理特征,包括吸烟史,瘤大小,瘤亚型,骨肌分化和细胞外粘液,与肺腺癌中的EGFR突变显著相关.
这些组织学特征有可能成为EGFR突变状态的预测标记,指导临床决策.

关键词:

在EGFR的突变.组织学组织学组织学肺部腺癌瘤是什么?分子病理学分子病理学病理学的病理学

更多相关视频

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

Published on: August 11, 2017

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on: June 26, 2019

相关概念视频

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...